Chronic Kidney Disease Mineral Bone Disorder (CKD-MBD) is a common complication of CKD, affecting bone health and mineral metabolism. It involves disturbances in calcium, phosphate, parathyroid hormone (PTH), and vitamin D levels, leading to bone pain, fractures, and cardiovascular issues.
This lecture will cover the definition and pathophysiology of CKD-MBD, explaining the underlying mechanisms of these metabolic changes. Managing CKD-MBD requires a comprehensive approach, from dietary adjustments to medications. However, the wide range of treatment options can be confusing, making it important to understand the rationale behind each choice.
This session will clarify the medication options available and their roles in controlling CKD-MBD, illustrated with a case study to demonstrate a practical approach to management.
Our Speaker
Dr. Ng Chee Yong
Renal Physician
Dr Ng Chee Yong is a renal physician, who sees patients with various kidney-related conditions such as chronic kidney disease, acute kidney injury, hypertension, glomerulonephritis and electrolytes imbalances. He provides kidney replacement therapies like hemodialysis and peritoneal dialysis as well as extracorporeal blood purifications in intensive care units, such as continuous kidney replacement therapies and therapeutic plasma exchange.
Dr Ng graduated from Faculty of Medicine, University of Malaya. After completing his Basic Specialist Training in Internal Medicine, he underwent Renal Senior Residency training in Singhealth, covering both Singapore General Hospital and Changi General Hospital. Thereafter, he joined Singhealth and continued to practise as a renal physician.
He was awarded a Health Manpower Development Program scholarship to pursue his special interest in Renal Osteodystrophy in Columbia University Medical Center, New York, USA.
He was an executive committee member of Singapore Society of Nephrology. Also invited as speaker for kidney conferences, such as National Kidney Foundation Kidney Care Conference and Singapore Society of Nephrology Annual Scientific Meeting.
Dr Ng was an investigator in an international pharmaceutical trial to retard progression of chronic kidney disease, which is now an approved new treatment for chronic kidney disease and heart disease. He presented in international conferences and published research articles in international journals.
To recognize his contribution to healthcare, he was conferred Singapore Health Quality Service Awards: Silver Award for Outstanding and Commendable contributions in 2023 and Hero Award for his contributions in the fight against the COVID-19 pandemic in 2021.
